Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

KIR genes and HLA class I ligands in Gaucher disease.

Vairo F, Portela P, Salim PH, Jobim M, Netto C, Dorneles A, Mittlestadt S, Jobim LF, Schwartz IV.

Gene. 2013 Mar 1;516(1):53-7. doi: 10.1016/j.gene.2012.12.014. Epub 2012 Dec 21.

2.

Human leukocyte antigens and Gaucher disease.

Vairo F, Portela P, Salim PH, Jobim M, Netto C, Dorneles A, Mittlestadt S, Jobim LF, Schwartz IV.

Blood Cells Mol Dis. 2013 Mar;50(3):202-5. doi: 10.1016/j.bcmd.2012.10.008. Epub 2012 Nov 14.

PMID:
23158683
3.

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF.

Int J Immunogenet. 2010 Jun;37(3):159-68. doi: 10.1111/j.1744-313X.2010.00906.x. Epub 2010 Feb 24.

PMID:
20193031
4.

Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.

Tajik N, Shah-hosseini A, Mohammadi A, Jafari M, Nasiri M, Radjabzadeh MF, Farnia P, Jalali A.

Tissue Antigens. 2012 Feb;79(2):90-6. doi: 10.1111/j.1399-0039.2011.01812.x. Epub 2011 Nov 30.

PMID:
22128749
5.

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF.

Ann Neurol. 2009 Jun;65(6):658-66. doi: 10.1002/ana.21695.

PMID:
19630074
6.

KIR2DS3 is associated with protection against acute myeloid leukemia.

Shahsavar F, Tajik N, Entezami KZ, Fallah Radjabzadeh M, Asadifar B, Alimoghaddam K, Ostadali Dahaghi M, Jalali A, Ghashghaie A, Ghavamzadeh A.

Iran J Immunol. 2010 Mar;7(1):8-17. doi: IJIv7i1A2.

7.

Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group.

Portela P, Jobim LF, Salim PH, Koff WJ, Wilson TJ, Jobim MR, Schwartsmann G, Roesler R, Jobim M.

Int J Immunogenet. 2012 Oct;39(5):423-8. doi: 10.1111/j.1744-313X.2012.01115.x. Epub 2012 Apr 10.

PMID:
22487023
8.

Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group.

Jobim MR, Jobim M, Salim PH, Portela P, Jobim LF, Leistner-Segal S, Bittelbrunn AC, Menke CH, Biazús JV, Roesler R, Schwartsmann G.

Hum Immunol. 2013 Sep;74(9):1130-3. doi: 10.1016/j.humimm.2013.06.021. Epub 2013 Jun 18.

PMID:
23792055
9.

Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.

Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M.

Cancer Immunol Immunother. 2005 Feb;54(2):172-8. Epub 2004 Jul 10.

PMID:
15248031
10.
11.

Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.

Beltrame LM, Sell AM, Moliterno RA, Clementino SL, Cardozo DM, Dalalio MM, Fonzar UJ, Visentainer JE.

Tissue Antigens. 2013 Dec;82(6):397-404. doi: 10.1111/tan.12256.

PMID:
24498996
12.

[Receptor-ligand analysis of killer cell Ig-like receptor in Jiangsu Han population].

Jiang LX, Xu LH, Qi CP, Wang YF.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Aug;28(8):863-5. Chinese.

PMID:
22863597
13.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

14.

Receptor systems controlling natural killer cell function are genetically stratified in Europe.

Guinan KJ, Cunningham RT, Meenagh A, Dring MM, Middleton D, Gardiner CM.

Genes Immun. 2010 Jan;11(1):67-78. doi: 10.1038/gene.2009.60. Epub 2009 Aug 20.

PMID:
19693090
15.

KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.

Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A.

Int J Immunogenet. 2011 Oct;38(5):403-9. doi: 10.1111/j.1744-313X.2011.01024.x. Epub 2011 Jul 29.

PMID:
21797986
16.

Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome.

Blum S, Csurhes P, Reddel S, Spies J, McCombe P.

J Neuroimmunol. 2014 Feb 15;267(1-2):92-6. doi: 10.1016/j.jneuroim.2013.12.007. Epub 2013 Dec 12.

PMID:
24367901
17.

KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.

Marangon AV, Silva GF, de Moraes CF, Grotto RM, Pardini MI, de Pauli DS, Sell AM, Visentainer JE, Moliterno RA.

Hum Immunol. 2011 Nov;72(11):1074-8. doi: 10.1016/j.humimm.2011.08.017. Epub 2011 Aug 28.

PMID:
21920398
18.

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC.

J Immunol. 2007 Nov 1;179(9):5977-89. Erratum in: J Immunol. 2007 Dec 15;179(12):8570.

19.

Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.

Keating SE, Ní Chorcora C, Dring MM, Stallings RL, O'Meara A, Gardiner CM.

Tissue Antigens. 2015 Sep;86(3):172-7. doi: 10.1111/tan.12608. Epub 2015 Jul 22.

PMID:
26202659
20.

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

Jobim M, Salim PH, Portela P, Wilson TJ, Fraportti J, Baronio D, Gil B, Penna LS, Roesler R, Jobim LF, Schwartsmann G.

Int J Immunogenet. 2010 Apr;37(2):83-9. doi: 10.1111/j.1744-313X.2009.00894.x. Epub 2010 Jan 14.

PMID:
20082646

Supplemental Content

Support Center